[Corrigendum] MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma <em>in vitro</em>

Yang,Yan; Li,Qing; Guo,Lili

doi:10.3892/mmr.2026.13879

June-2026 Volume 33 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

June-2026 Volume 33 Issue 6

Full Size Image

Correction Open Access

[Corrigendum] MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro

Authors:
- Yan Yang
- Qing Li
- Lili Guo
View Affiliations / Copyright

Affiliations: Clinical Laboratory, South Region of Jingmen No. 1 People's Hospital, Jingmen, Hubei 448000, P.R. China, Clinical Laboratory, North Region of Jingmen No. 1 People's Hospital, Jingmen, Hubei 448000, P.R. China, Clinical Laboratory, Jingmen No. 2 People's Hospital, Jingmen, Hubei 448000, P.R. China

Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 169
|
Published online on: April 15, 2026

https://doi.org/10.3892/mmr.2026.13879
Expand metrics +

Article

Mol Med Rep 17: [Related article:] 8244–8252, 2018; DOI: 10.3892/mmr.2018.8894

Subsequently to the publication of the above article, an interested reader drew to the authors' attention that, concerning the cell migration and invasion assay experiments in Fig. 2C and D on p. 8248, a number of data panels contained overlapping sections, such that data which were shown to represent different experimental conditions had been derived from a smaller number of orginal sources.

Figure 2.

miR-122 suppresses cell proliferation, migration and invasion in NPC cells. (A) The significantly elevated expression of miR-122 in NPC cells transfected with miR-122 mimics. (B) Relative cell survival, demonstrated using Cell Counting kit-8 methods. Data are presented as the mean ± standard deviation, n=3. *P<0.05 and **P<0.01 vs. control. Representative images of the (C) migratory and (D) invasive abilities of NPC cells transfected with miR-122 are presented (magnification, ×100). (E) miR-122 inhibited the migratory ability of NPC cells. (F) miR-122 inhibited the invasive ability of NPC cells. Data are presented as the mean ± standard deviation, n=4. **P<0.01 vs. control. NPC, nasopharyngeal carcinoma; miR, microRNA; NC, negative control; Con, control.

Given the time that has elapsed since this paper was published, the authors no longer had access to their original data, but were willing to repeat these experiments, and the revised version of Fig. 2 is shown on the next page. The results obtained were broadly similar to those obtained originally, and therefore the replacement of the original data in this figure with the new data does not affect the reported conclusions of this study. All the authors agree with the publication of this Corrigendum, and are grateful to the Editor of Molecular Medicine Reports for allowing this to be published. They also regret the errors that existed in the original figure, and apologize to the readership for any confusion that may have been caused.